| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780598 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
There was a reduction in risk of endometrial cancer among statin users at baseline but not in time-dependent models. Pravastatin use was associated with an increased risk of ovarian cancer. Analyses of larger numbers of cases are needed to evaluate these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Pinkal Desai, Robert Wallace, Matthew L. Anderson, Barbara V. Howard, Roberta M. Ray, Chunyuan Wu, Monika Safford, Lisa W. Martin, Thomas Rohan, JoAnn E. Manson, Michael S. Simon,